Ligand profile
164
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00976 — 2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase
Identifiers
Database identifiers and provenance.
- Ligand ID
164- PDB
4myd- UniProt (similar protein)
P37355- Target protein
- KP13_00976
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 111.9
- −1 ≤ LogP ≤ 5 -0.02
- MW ≤ 500 Da 240.2
- LogP ≤ 5 -0.02
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 111.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1=C[C@H]([C@@H](C(=C1)C(=O)CCC(=O)O)C(=O)O)OC1=C[C@H]([C@@H](C(=C1)C(=O)CCC(=O)O)C(=O)O)O
InChI=1S/C11H12O6/c12-7(4-5-9(14)15)6-2-1-3-8(13)10(6)11(16)17/h1-3,8,10,13H,4-5H2,(H,14,15)(H,16,17)/t8-,10-/m1/s1InChI=1S/C11H12O6/c12-7(4-5-9(14)15)6-2-1-3-8(13)10(6)11(16)17/h1-3,8,10,13H,4-5H2,(H,14,15)(H,16,17)/t8-,10-/m1/s1
QJYRAJSESKVEAE-PSASIEDQSA-NQJYRAJSESKVEAE-PSASIEDQSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF12697
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 164 →
- PDB RCSB structure 4myd →
- UniProt UniProt P37355 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “164”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00976.
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).